Barbara Hunt

Appearances

VONOPRAZAN FOR THE TREATMENT OF HEARTBURN IN NON-EROSIVE REFLUX DISEASE: A RANDOMIZED TRIAL
Date
May 20, 2024
BACKGROUND: Proton pump inhibitors (PPIs) are the mainstay of therapy for non-erosive reflux disease (NERD). Potassium-competitive acid blockers (PCABs) have more potent and rapid inhibition of gastric acid secretion than PPIs…
Presenter
Loren Laine
Yale School of Medicine
Speakers
Stuart Spechler
Baylor University Medical Center at Dallas
Rena Yadlapati
University of California San Diego
Felice Schnoll-Sussman
Weill Cornell Medical Center
Neila Smith
Eckhard Leifke
Tom Harris
Barbara Hunt
Ronnie Fass
Case Western Reserve University
Philip Katz